Indocyanine Green
Gastrointestinal Neoplasms
Saint Petersburg State University, RussiaSmall moleculeN/AActive
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 81/ 100
Competitive context
16 Active assets in the Gastrointestinal Neoplasms cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Capecitabine China Medical University, China | Phase 3 | BB |
Eloxatin Janssen Research & Development, LLC | Phase 3 | BB |
Irinotecan Pfizer | Phase 3 | BB |
FLUOROURACILUM Janssen Research & Development, LLC | Phase 3 | BB |
Calcium folinate pentahydrate Janssen Research & Development, LLC | Phase 3 | BB |
View all 34 →
Same molecule, other indications
Indocyanine Green is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →